Search

Your search keyword '"Arora, Vipin"' showing total 236 results

Search Constraints

Start Over You searched for: Author "Arora, Vipin" Remove constraint Author: "Arora, Vipin" Search Limiters Full Text Remove constraint Search Limiters: Full Text
236 results on '"Arora, Vipin"'

Search Results

4. Challenges and Opportunities in IBD Clinical Trial Design

7. Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies

16. Changes in health-related quality of life and associations with improvements in clinical efficacy: a Phase 2 study of mirikizumab in patients with ulcerative colitis

21. Risk Benefit Analysis of Routine Thymectomy for Differentiated Thyroid Cancers: A Systematic Review

24. Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis

25. 867e: EFFICACY AND SAFETY OF MIRIKIZUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 LUCENT-2 STUDY

26. 884: EFFICACY AND SAFETY OF MIRIKIZUMAB AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 LUCENT-1 STUDY

27. A Critical Review on the Understanding and Management of Vatarakta: DOI: 10.47223/IRJAY.2022.5719

28. A Critical Review on the Understanding and Management of Vatarakta

29. Disease Burden and Patient-Reported Outcomes Among Ulcerative Colitis Patients According to Therapy at Enrollment Into CorEvitas’ Inflammatory Bowel Disease Registry

32. Multidetector Computed Tomography Perfusion in Head and Neck Squamous Cell Carcinomas: Evaluation of a Dose Reduction Strategy.

33. Challenges and Opportunities in IBD Clinical Trial Design

39. 132 EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

42. Systemic administration of a β2-adrenergic receptor agonist reduces mechanical allodynia and suppresses the immune response to surgery in a rat model of persistent post-incisional hypersensitivity

46. Tu1888 EARLY AND SUSTAINED IMPROVEMENT IN STOOL FREQUENCY AND RECTAL BLEEDING FOLLOWING 52 WEEKS OF MIRIKIZUMAB TREATMENT

49. Su1967 DISEASE BURDEN AND PATIENT-REPORTED OUTCOME MEASURES AMONG ULCERATIVE COLITIS PATIENTS ACCORDING TO THERAPY AT ENROLLMENT INTO THE CORRONA IBD REGISTRY

Catalog

Books, media, physical & digital resources